जर्नल ऑफ़ रेस्पिरेटरी मेडिसिन

अमूर्त

Respiratory Mucosa in Patients with Chronic Obstructive Pulmonary Dysfunction

Kjell E J H

The vast majority of pulmonary medications are used to promote broncho-dilation and improve alveolar ventilation and oxygenation. These effects should improve an individual's ability to exercise and more effectively develop training effects. Because of the side effects of many pulmonary medications, however, exercise tolerance and the normal adaptations to habitual exercise conditioning may be retarded. The following section is not presented to discourage the use of these medications nor of exercise training; rather, it should highlight the important role exercise has for patients with pulmonary disease who are taking pulmonary medications.